Luxa Biotechnologyluxabiois A Clinical Stage Biotechnology Company Developing A Novel Adult Rpe Stem Cellrpesctherapy For Dry Amdthe Proprietary Adult Rpesc Derived Rpe Stem Cell Product Was Developed At And Licensed From The Nsciluxabio Is A Partnership Between The Nsci Research Institute And Y2 Solutiona Korean Company To Evaluate Rpesc In A Clinical Trial To Test The Safety And Efficacy Of Rpe Progenitor Stage Progeny As A Potential Therapy For Dry Amdluxabio Maintains A Robust Research Program At Nsci To Develop The Rpesc As An Effectivecommercially Viable Cell Productthe Phase 1 2A Clinical Trial Of Rpesc Rpe 4W For The Treatment Of Dry Age Related Macular Degeneration Includes The Cedars Sinai Biomanufacturing Centeremmesthe University Of Michigan Kellogg Eye Centerthe National Eye Institute
No conferences found for this company.
| Company Name | Luxa Biotechnology Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
